Finerenone trials for Chronic kidney disease

All Finerenone trials · All Chronic kidney disease trials

Phase breakdown

Recruiting trials studying Finerenone for Chronic kidney disease

• A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
  NCT07239570 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 4 locations
• Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease
  NCT06838416 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
  NCT06058585 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 43 locations
• Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease
  NCT06727409 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study Finerenone for Chronic kidney disease?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.